The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Nanog regulates self-renewal of cancer stem cells through the insulin-like growth factor pathway in human hepatocellular carcinoma
Open accessAbstract
Hepatocellular carcinoma (HCC) exhibits cellular heterogeneity and embryonic stem-cell–related genes are preferentially overexpressed in a fraction of cancer cells of poorly differentiated tumors. However, it is not known whether or how these cancer cells contribute to tumor initiation and progression. Here, our data showed that increased expression of pluripotency transcription factor Nanog in cancer cells correlates with a worse clinical outcome in HCC. Using the Nanog promoter as a reporter system, we could successfully isolate a small subpopulation of Nanog-positive cells. We demonstrate that Nanog-positive cells exhibited enhanced ability of self-renewal, clonogenicity, and initiation of tumors, which are consistent with crucial hallmarks in the definition of cancer stem cells (CSCs). NanogPos CSCs could differentiate into mature cancer cells in in vitro and in vivo conditions. In addition, we found that NanogPos CSCs exhibited resistance to therapeutic agents (e.g., sorafenib and cisplatin) and have a high capacity for tumor invasion and metastasis. Knock-down expression of Nanog in NanogPos CSCs could decrease self-renewal accompanied with decreased expression of stem-cell–related genes and increased expression of mature hepatocyte-related genes. Overexpression of Nanog in NanogNeg cells could restore self-renewal. Furthermore, we found that insulin-like growth factor (IGF)2 and IGF receptor (IGF1R) were up-regulated in NanogPos CSCs. Knock-down expression of Nanog in NanogPos CSCs inhibited the expression of IGF1R, and overexpression of Nanog in NanogNeg cells increased the expression of IGF1R. A specific inhibitor of IGF1R signaling could significantly inhibit self-renewal and Nanog expression, indicating that IGF1R signaling participated in Nanog-mediated self-renewal. Conclusion : These data indicate that Nanog could be a novel biomarker for CSCs in HCC, and that Nanog could play a crucial role in maintaining the self-renewal of CSCs through the IGF1R-signaling pathway.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Human infections with V. vulnificus and their laboratory models often terminate in septic shock (Shan et al., 2012).”
From Hepcidin-Induced Hypoferremia Is a Critical Host Defense Mechanism against the Siderophilic Bacterium Vibrio vulnificus (2015) · cites this paper as Shan et al., 2012
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells
Mani, S. A., Guo, W., Liao, M.-J., Eaton, E. N., Ayyanan, A., Zhou, A. Y., Brooks, M. W., Reinhard, F., Zhang, C. C., Shipitsin, M. V., et al. (2008) · Cell · doi:10.1016/j.cell.2008.03.027 · Cited by 8,839
Cancer stem cells in solid tumours: accumulating evidence and unresolved questions
Visvader, J. E., & Lindeman, G. J. (2008) · Nature reviews. Cancer · doi:10.1038/nrc2499 · Cited by 3,501
Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits
Polyak, K., & Weinberg, R. A. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2620 · Cited by 3,302
EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer
Singh, A., & Settleman, J. (2010) · Oncogene · doi:10.1038/onc.2010.215 · Cited by 2,545
Hepatocellular carcinoma pathogenesis: from genes to environment
Farazi, P. A., & DePinho, R. A. (2006) · Nature reviews. Cancer · doi:10.1038/nrc1934 · Cited by 2,019
Wnt activity defines colon cancer stem cells and is regulated by the microenvironment
Vermeulen, L., De Sousa E Melo, F., van der Heijden, M., Cameron, K., de Jong, J. H., Borovski, T., Tuynman, J. B., Todaro, M., Merz, C., Rodermond, H., et al. (2010) · Nature Cell Biology · doi:10.1038/ncb2048 · Cited by 1,804
Heterogeneity in Cancer: Cancer Stem Cells versus Clonal Evolution
Shackleton, M. J., Quintana, E., Fearon, E. R., & Morrison, S. J. (2009) · Cell · doi:10.1016/j.cell.2009.08.017 · Cited by 1,204
Significance of CD90+ Cancer Stem Cells in Human Liver Cancer
Yang, Z. F., Ho, D. W., Ng, M. N., Lau, C. K., Yu, W. C., Ngai, P., Chu, P., Lam, C. T., Poon, R. T. P., & Fan, S. T. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.01.013 · Cited by 1,188
Self-citationYamashita, T., Ji, J., Budhu, A., Forgues, M., Yang, W., Wang, H., Jia, H., Ye, Q., Qin, L., Wauthier, E., et al. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.12.004 · Cited by 1,142
Lin28 promotes transformation and is associated with advanced human malignancies
Viswanathan, S. R., Powers, J. T., Einhorn, W. S., Hoshida, Y., Ng, T., Toffanin, S., O’Sullivan, M. J., Lü, J., Phillips, L. A., Lockhart, V. L., et al. (2009) · Nature Genetics · doi:10.1038/ng.392 · Cited by 835
Flagged first, then by citations
Cited by
Sorted by citations
Epigenetic modulators, modifiers and mediators in cancer aetiology and progression
Feinberg, A. P., Koldobskiy, M. A., & Göndör, A. (2016) · Nature Reviews Genetics · doi:10.1038/nrg.2016.13 · Cited by 841
Sustained proliferation in cancer: Mechanisms and novel therapeutic targets
Feitelson, M. A., Arzumanyan, A. L., Kulathinal, R. J., Blain, S. W., Holcombe, R. F., Mahajna, J. A., Marino, M., Martínez‐Chantar, M. L., Nawroth, R., Sánchez-García, I., et al. (2015) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2015.02.006 · Cited by 818
Cancer stem cells in hepatocellular carcinoma — from origin to clinical implications
Lee, T. K., Guan, X., & Ma, S. (2021) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-021-00508-3 · Cited by 463
Chen, W.-J., Ho, C., Chang, Y., Chen, H., Ling, T., Ling, T., Yuan, S., Yuan, S.-S., Chen, Y.-J. L., Lin, C.-Y., et al. (2014) · Nature Communications · doi:10.1038/ncomms4472 · Cited by 448
Insulin Receptor Isoforms in Physiology and Disease: An Updated View
Belfiore, A., Malaguarnera, R., Vella, V., Lawrence, M. C., Sciacca, L., Frasca, F., Morrione, A., & Vigneri, R. (2017) · Endocrine Reviews · doi:10.1210/er.2017-00073 · Cited by 390
Mechanisms of drug resistance in HCC
Ladd, A. D., Duarte, S. M., Şahin, İ., & Zarrinpar, A. (2023) · Hepatology · doi:10.1097/hep.0000000000000237 · Cited by 379
Yuan, J.-H., Liu, X.-N., Wang, T.-T., Pan, W., Tao, Q.-F., Zhou, W.-P., Wang, F., & Sun, S.-H. (2017) · Nature Cell Biology · doi:10.1038/ncb3538 · Cited by 367
Denduluri, S. K., Idowu, O. A., Wang, Z., Liao, Z., Yan, Z., Mohammed, M. K., Ye, J., Wei, Q., Wang, J., Zhao, L., et al. (2014) · Genes & Diseases · doi:10.1016/j.gendis.2014.10.004 · Cited by 333
The evolving concept of liver cancer stem cells
Nio, K., Yamashita, T., & Kaneko, S. (2017) · Molecular Cancer · doi:10.1186/s12943-016-0572-9 · Cited by 278
Targeted therapy for hepatocellular carcinoma: Challenges and opportunities
Chen, S., Cao, Q., Wen, W., & Wang, H. (2019) · Cancer Letters · doi:10.1016/j.canlet.2019.114428 · Cited by 253
Chen, J., Jin, R., Zhao, J., Liu, J., Ying, H., Yan, H., Zhou, S., Liang, Y., Huang, D., Liang, X. H., et al. (2015) · Cancer Letters · doi:10.1016/j.canlet.2015.06.019 · Cited by 253
Self-citationThe significance of intertumor and intratumor heterogeneity in liver cancer
Liu, J., Dang, H. T., & Wang, X. W. (2018) · Experimental & Molecular Medicine · doi:10.1038/emm.2017.165 · Cited by 255
Self-citationJeter, C. R., Yang, T., Wang, J., Chao, H., & Tang, D. G. (2015) · Stem Cells · doi:10.1002/stem.2007 · Cited by 251
Wu, C. X., Wang, X. Q., Chok, K., Man, K., Tsang, S. H. Y., Chan, A. C. Y., Wing, K., Xia, W. G., & Cheung, T. T. (2018) · Theranostics · doi:10.7150/thno.25487 · Cited by 228
Arezes, J., Jung, G., Gabayan, V., Valore, E., Ruchala, P., Gulig, P. A., Ganz, T., Nemeth, E., & Bulut, Y. (2015) · Cell Host & Microbe · doi:10.1016/j.chom.2014.12.001 · Cited by 227
“Human infections with V. vulnificus and their laboratory models often terminate in septic shock (Shan et al., 2012).”
BackgroundPluripotency transcription factors and cancer stem cells: small genes make a big difference
Liu, A., Yu, X., & Liu, S. (2013) · 癌症：英文版 · doi:10.5732/cjc.012.10282 · Cited by 231
Tovar, V., Cornellà, H., Moeini, A., Vidal, S. J., Hoshida, Y., Sia, D., Peix, J., Cabellos, L., Alsinet, C., Torrecilla, S., et al. (2015) · Gut · doi:10.1136/gutjnl-2015-309501 · Cited by 204
Lo, J. H. T., Lau, E. Y.-T., Ching, R. H. H., Cheng, B. Y.-L., Ma, M. K. F., Ng, I. O., & Lee, T. K. (2015) · Hepatology · doi:10.1002/hep.27859 · Cited by 199
Niu, L., Liu, L., Yang, S., Ren, J., Lai, P. B. S., & Chen, G. G. (2017) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2017.10.002 · Cited by 198
Self-citationvan Schaijik, B., Davis, P. F., Wickremesekera, A., Tan, S. T., & Itinteang, T. (2017) · Journal of Clinical Pathology · doi:10.1136/jclinpath-2017-204815 · Cited by 201
Liu, S., Li, N., Yu, X., Xiao, X., Cheng, K., Hu, J., Wang, J., Zhang, D., Cheng, S., & Liu, S. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.01.046 · Cited by 193
Role of IGF1R in Breast Cancer Subtypes, Stemness, and Lineage Differentiation
Farabaugh, S. M., Boone, D. N., & Lee, A. V. (2015) · Frontiers in Endocrinology · doi:10.3389/fendo.2015.00059 · Cited by 190
Yong, X., Tang, B., Xiao, Y., Xie, R., Qin, Y., Luo, G., Hu, C.-J., Dong, H. F., & Yang, S. (2016) · Cancer Letters · doi:10.1016/j.canlet.2016.02.032 · Cited by 176
Targeting cancer stem cells: emerging role of Nanog transcription factor
Wu, C., Wang, M., & Chiou, S.-H. (2013) · OncoTargets and Therapy · doi:10.2147/ott.s38114 · Cited by 174
Xu, Y., Huang, J., Ma, L., Shan, J., Shen, J., Yang, Z., Liu, L., Luo, Y., Yao, C., & Qian, C. (2016) · Cancer Letters · doi:10.1016/j.canlet.2015.11.034 · Cited by 148
Self-citationDiet and liver cancer risk: a narrative review of epidemiological evidence
Yang, W., Zeng, X., Liu, Z., Zhao, Q.-H., Tan, Y., Gao, J., Li, H., & Xiang, Y. (2020) · British Journal Of Nutrition · doi:10.1017/s0007114520001208 · Cited by 166
Liu, C., Liu, L., Chen, X., Shen, J., Shan, J., Xu, Y., Yang, Z., Wu, L., Xia, F., Bie, P., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0062828 · Cited by 161
Self-citationThe Links Between Insulin Resistance, Diabetes, and Cancer
Orgel, E., & Mittelman, S. D. (2012) · Current Diabetes Reports · doi:10.1007/s11892-012-0356-6 · Cited by 168
Cancer stem cells (CSCs), cervical CSCs and targeted therapies
Huang, R., & Rofstad, E. K. (2016) · Oncotarget · doi:10.18632/oncotarget.10169 · Cited by 162
Simon, T. G., King, L. Y., Chong, D. Q., Nguyen, L. H., Ma, Y., VoPham, T., Giovannucci, E. L., Fuchs, C. S., Meyerhardt, J. A., Corey, K. E., et al. (2018) · Hepatology · doi:10.1002/hep.29660 · Cited by 160
Notch and Wnt/β-catenin signaling pathway play important roles in activating liver cancer stem cells
Wang, R., Sun, Q., Wang, P., Liu, M., Xiong, S., Luo, J., Huang, H., Du, Q., Geller, D. A., & Cheng, B. (2015) · Oncotarget · doi:10.18632/oncotarget.6805 · Cited by 159
Liu, C., Liu, L., Chen, X., Cheng, J., Zhang, H., Shen, J., Shan, J., Xu, Y., Yang, Z., Lai, M., et al. (2016) · Hepatology · doi:10.1002/hep.28509 · Cited by 148
Self-citationThe Emerging Role of Insulin and Insulin-Like Growth Factor Signaling in Cancer Stem Cells
Malaguarnera, R., & Belfiore, A. (2014) · Frontiers in Endocrinology · doi:10.3389/fendo.2014.00010 · Cited by 147
WNT/β-Catenin Directs Self-Renewal Symmetric Cell Division of hTERThigh Prostate Cancer Stem Cells
Zhang, K., Guo, Y., Wang, X., Zhao, H., Ji, Z., Cheng, C., Li, L., Fang, Y., Xu, D., Zhu, H. H., et al. (2017) · Cancer Research · doi:10.1158/0008-5472.can-16-1887 · Cited by 134
Emerging role of nanog in tumorigenesis and cancer stem cells
Santaliz-Ruiz, L. E. I., Xie, X., Old, M. O., Teknos, T. N., & Pan, Q. (2013) · International Journal of Cancer · doi:10.1002/ijc.28690 · Cited by 136
piR-55490 inhibits the growth of lung carcinoma by suppressing mTOR signaling
Peng, L., Song, L., Liu, C., Lv, X., Li, X., Jie, J., Zhao, D., & Li, D. (2015) · Tumor Biology · doi:10.1007/s13277-015-4056-0 · Cited by 129
The role of NANOG transcriptional factor in the development of malignant phenotype of cancer cells
Gawlik-Rzemieniewska, N., & Bednarek, I. A. (2015) · Cancer Biology & Therapy · doi:10.1080/15384047.2015.1121348 · Cited by 131
Liu, C., Liu, L., Chen, X., Cheng, J., Zhang, H., Zhang, C., Shan, J., Shen, J., & Qian, C. (2017) · Cancer Research · doi:10.1158/0008-5472.can-17-1236 · Cited by 133
Self-citationLai, S.-C., Su, Y.-T., Chi, C.-C., Kuo, Y.-C., Lee, K.-F., Wu, Y.-C., Lan, P.-C., Yang, M.-H., Chang, T.-S., & Huang, Y.-H. (2019) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-019-1442-2 · Cited by 128
Hepatocellular carcinoma and lifestyles
Saran, U., Humar, B., Kolly, P., & Dufour, J. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.08.028 · Cited by 126
Li, X., Chen, C. Y., Xiang, D., Qu, L., Sun, W. C., Lu, X., Zhou, T., Chen, S., Ning, B., Cheng, Z., et al. (2017) · Hepatology · doi:10.1002/hep.29372 · Cited by 125
Yao, C., Su, L., Shan, J., Zhu, C., Liu, L., Liu, C., Xu, Y., Yang, Z., Bian, X., Shao, J., et al. (2016) · Stem Cells · doi:10.1002/stem.2320 · Cited by 123
Self-citationLi, H., Batth, I. S., Qu, X., Xu, L., Song, N., Wang, R., & Liu, Y. (2017) · Molecular Cancer · doi:10.1186/s12943-016-0576-5 · Cited by 125
Xiong, S., Wang, R., Chen, Q., Luo, J., Wang, J., Zhao, Z., Li, Y., Wang, Y., Wang, X., & Cheng, B. (2018) · PubMed Central · Cited by 122
Lei, Z.-J., Wang, J., Xiao, H.-L., Guo, Y., Wang, T., Li, Q., Liu, L., Luo, X., Fan, L.-L., Li, L., et al. (2015) · Oncogene · doi:10.1038/onc.2015.129 · Cited by 116
Self-citationHuan, H.-B., Wen, X.-D., Chen, X., Wu, L., Wu, L., Zhang, L., Yang, D.-P., Zhang, X., Bie, P., Qian, C., et al. (2016) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2016.08.016 · Cited by 117
Self-citationCancer stem cells in hepatocellular carcinoma: an overview and promising therapeutic strategies
Wang, N., Wang, S., Li, M., Hu, B., Liu, L., Yang, S., Yang, S., Gong, Z., Lai, P. B. S., & Chen, G. G. (2018) · Therapeutic Advances in Medical Oncology · doi:10.1177/1758835918816287 · Cited by 116
Self-citationSun, C., Sun, L., Li, Y., Kang, X., Zhang, S., & Liu, Y. (2013) · Medical Oncology · doi:10.1007/s12032-013-0503-1 · Cited by 111
Chang, W., Lin, R., Yu, J., Chang, W., Fu, C.-H., Lai, A. C., Yu, A. L.-T., & Yu, A. L.-T. (2013) · Breast Cancer Research · doi:10.1186/bcr3423 · Cited by 108
Nanog, as a key cancer stem cell marker in tumor progression
Vasefifar, P., Motafakkerazad, R., Maleki, L. A., Najafi, S., Ghorbaninezhad, F., Najafzadeh, B., Alemohammad, H., Amini, M. A., Baghbanzadeh, A., & Baradaran, B. (2022) · Gene · doi:10.1016/j.gene.2022.146448 · Cited by 106
Regulation of NANOG in cancer cells
Gong, S., Li, Q., Jeter, C. R., Fan, Q., Tang, D. G., & Liu, B. (2015) · Molecular Carcinogenesis · doi:10.1002/mc.22340 · Cited by 105
Wang, P., Wan, W., Xiong, S., Feng, H., & Wu, N. (2017) · Cell Death Discovery · doi:10.1038/cddiscovery.2016.105 · Cited by 103
Cancer stem cells and niches: challenges in immunotherapy resistance
Pan, Y., Yuan, C., Zeng, C., Sun, C., Xia, L., Wang, G., Chen, X., Zhang, B., Liu, J., & Ding, Z. (2025) · Molecular Cancer · doi:10.1186/s12943-025-02265-2 · Cited by 117
Self-citationLiu, L., Liu, C., Zhang, Q., Shen, J., Zhang, H., Shan, J., Duan, G., Guo, D., Chen, X., Cheng, J., et al. (2016) · Hepatology · doi:10.1002/hep.28690 · Cited by 102
Self-citationRasti, A., Mehrazma, M., Madjd, Z., Abolhasani, M., Zanjani, L. S., & Asgari, M. (2018) · Scientific Reports · doi:10.1038/s41598-018-30168-4 · Cited by 103
Schulenburg, A., Blatt, K., Cerny‐Reiterer, S., Sadovnik, I., Herrmann, H., Marian, B., Grunt, T. W., Zielinski, C. C., & Valent, P. (2015) · Journal of Hematology & Oncology · doi:10.1186/s13045-015-0113-9 · Cited by 95
Chang, T., Wu, Y.-C., Chi, C., Su, W.-C., Chang, P., Lee, K.-F., Tung, T.-H., Wang, J., Liu, J., Tung, S., et al. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-3274 · Cited by 92
Self-citationStrategies for Isolating and Enriching Cancer Stem Cells: Well Begun Is Half Done
Duan, J., Qiu, W., Xu, S., Wang, B., Ye, X.-Z., Ping, Y., Zhang, X., Bian, X., & Yu, S. (2013) · Stem Cells and Development · doi:10.1089/scd.2012.0613 · Cited by 90
Self-citationMa, L., Liu, J., Liu, L., Duan, G., Wang, Q., Xu, Y., Xia, F., Shan, J., Shen, J., Yang, Z., et al. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-2171 · Cited by 91
Self-citationCharacteristics of liver cancer stem cells and clinical correlations
Cheng, Z., Li, X., & Ding, J. (2015) · Cancer Letters · doi:10.1016/j.canlet.2015.07.041 · Cited by 88
Heterogeneity of hepatocellular carcinoma contributes to cancer progression
Jeng, K., Chang, C., Jeng, W., Sheen, I., & Jeng, C. (2015) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2015.01.009 · Cited by 87
Cao, J., Zhao, M., Liu, J., Zhang, X., Pei, Y., Wang, J., Yang, X. Y., Shen, B., & Zhang, J. (2019) · Theranostics · doi:10.7150/thno.29271 · Cited by 85
Self-citationSun, C., Sun, L., Jiang, K., Gao, D., Kang, X., Wang, C., Zhang, S., Huang, S., Qin, X. Y., Yan, L., et al. (2013) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2013.02.017 · Cited by 85
Wei, Z., Jia, J., Heng, G., Xu, H., Shan, J., Wang, G., Liu, C., Xia, J., Zhou, H., Wu, M. C., et al. (2019) · Hepatology · doi:10.1002/hep.30622 · Cited by 83
Self-citationLuo, J., Wang, P., Wang, R., Wang, J., Liu, M., Xiong, S., Li, Y., & Cheng, B. (2015) · Oncotarget · doi:10.18632/oncotarget.6672 · Cited by 80
Jin, H., Wang, C., Jin, G., Ruan, H., Gu, D., Wei, L., Wang, H., Wang, N., Arunachalam, E., Zhang, Y., et al. (2017) · Gastroenterology · doi:10.1053/j.gastro.2017.05.045 · Cited by 81
Wang, T., Qin, Z., Wen, L., Guo, Y., Liu, Q., Lei, Z., Pan, W. X., Liu, K., Wang, X., Lai, S., et al. (2018) · Cell Death and Differentiation · doi:10.1038/s41418-018-0095-6 · Cited by 82
Self-citationLiu, C., Liu, L., Shan, J., Shen, J., Xu, Y., Zhang, Q., Yang, Z., Wu, L., Xia, F., Bie, P., et al. (2013) · Cancer Letters · doi:10.1016/j.canlet.2013.07.022 · Cited by 79
Self-citationInsulin and cancer: a tangled web
Leitner, B. P., Siebel, S., Akingbesote, N. D., Zhang, X., & Perry, R. J. (2022) · Biochemical Journal · doi:10.1042/bcj20210134 · Cited by 79
Kim, I. G., Kim, S. Y., Choi, S., Lee, J. H., Kim, K. C., & Cho, E. (2013) · Oncogene · doi:10.1038/onc.2013.373 · Cited by 77
Su, L., Luo, Y., Yang, Z., Yang, H. J., Yao, C., Cheng, F., Shan, J., Chen, J., Li, F., Liu, L., et al. (2016) · Cancer Research · doi:10.1158/0008-5472.can-16-0246 · Cited by 77
Self-citationNgo, M.-H. T., Jeng, H.-Y., Kuo, Y., Nanda, J. D., Brahmadhi, A., Ling, T., Chang, T., & Huang, Y. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22041931 · Cited by 79
Liu, Y., Wan, G., Guo, H., Liu, Y., Zhou, P., Wang, H., Wang, D., Zhang, S., Wang, Y., & Zhang, N. (2017) · Nano Research · doi:10.1007/s12274-016-1339-8 · Cited by 76
Kim, J., Lee, H., Park, K.-K., Choi, Y., Nam, J., & Hong, I. (2016) · Oncotarget · doi:10.18632/oncotarget.7954 · Cited by 74
Liu, S., Sun, J. P., Cai, B., Xi, X., Yang, L., Zhang, Z., Feng, Y., & Sun, Y. (2016) · Tumor Biology · doi:10.1007/s13277-016-4848-x · Cited by 74
Sun, L., Beggs, K. M., Borude, P. C., Edwards, G., Bhushan, B., Walesky, C. M., Roy, N., Manley, M. W., Gunewardena, S., O’Neil, M. F., et al. (2016) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00027.2015 · Cited by 70
Tang, M., Yang, M., Wu, G., Mo, S., Wu, X., Zhang, S., Yu, R., Hu, Y., Xu, Y., Li, Z., et al. (2021) · Cancer Research · doi:10.1158/0008-5472.can-21-0436 · Cited by 69
Self-citationGigantol Suppresses Cancer Stem Cell-Like Phenotypes in Lung Cancer Cells
Bhummaphan, N., & Pithi Chanvorachote, B. (2015) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2015/836564 · Cited by 71
Zheng, F.-M., Long, Z., Hou, Z.-J., Luo, Y., Xu, L.-Z., Xia, J.-L., Lai, X.-J., Liu, J.-W., Wang, X., Muhammad, K. I., et al. (2014) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-13-1029 · Cited by 65
Self-citationSympathetic and parasympathetic innervation in hepatocellular carcinoma
Zhang, L., Wu, L. L., Huan, H.-B., Chen, X., Wen, X. D., Yang, D. P., & Xia, F. (2017) · Neoplasma · doi:10.4149/neo_2017_605 · Cited by 70
Self-citationTherapy-induced enrichment of cancer stem-like cells in solid human tumors: Where do we stand?
Martins‐Neves, S. R., Cleton-Jansen, A., & Gomes, C. M. F. (2018) · Pharmacological Research · doi:10.1016/j.phrs.2018.10.011 · Cited by 70
Insights into the Nanog gene: A propeller for stemness in primitive stem cells
Zhang, W., Sui, Y., Ni, J., & Yang, T. (2016) · International Journal of Biological Sciences · doi:10.7150/ijbs.16349 · Cited by 65
PPARδ Mediates the Effect of Dietary Fat in Promoting Colorectal Cancer Metastasis
Wang, D., Fu, L., Wei, J., Xiong, Y., & DuBois, R. N. (2019) · Cancer Research · doi:10.1158/0008-5472.can-19-0384 · Cited by 64
Kumar, S., Raina, K., Agarwal, C., & Agarwal, R. (2014) · Oncotarget · doi:10.18632/oncotarget.2068 · Cited by 63
The Recent Advances on Liver Cancer Stem Cells: Biomarkers, Separation, and Therapy
Xiao, Y., Lin, M., Jiang, X., Ye, J., Guo, T., Shi, Y., & Bian, X. (2017) · Analytical Cellular Pathology · doi:10.1155/2017/5108653 · Cited by 61
Self-citationEpithelial cell senescence induces pulmonary fibrosis through Nanog-mediated fibroblast activation
Chen, X., Xu, H., Hou, J., Wang, H., Zheng, Y., Li, H., Cai, H., Han, X., & Dai, J. (2019) · Aging · doi:10.18632/aging.102613 · Cited by 60
The oncogenic potential of NANOG: An important cancer induction mediator
Najafzadeh, B., Asadzadeh, Z., azad, R. M., Mokhtarzadeh, A., Baghbanzadeh, A., Alemohammad, H., Shadbad, M. A., Vasefifar, P., Najafi, S., & Baradaran, B. (2020) · Journal of Cellular Physiology · doi:10.1002/jcp.30063 · Cited by 58
The Clinical Potential of Targeted Nanomedicine: Delivering to Cancer Stem-like Cells
Kim, S. S., Rait, A. S., Rubab, F., Rao, A. K., Kiritsy, M. C., Pirollo, K. F., Wang, S., Weiner, L. M., & Chang, E. H. (2013) · Molecular Therapy · doi:10.1038/mt.2013.231 · Cited by 56
Maharati, A., & Moghbeli, M. (2023) · Journal of Translational Medicine · doi:10.1186/s12967-023-04434-7 · Cited by 53
Reprogramming and Carcinogenesis—Parallels and Distinctions
Wasik, A. M., Grabarek, J., Pantovic, A., Cieślar‐Pobuda, A., Asgari, H. R., Bundgaard‐Nielsen, C., Rafat, M., Dixon, I., Ghavami, S., & Łoś, M. (2014) · International review of cytology · doi:10.1016/b978-0-12-800097-7.00005-1 · Cited by 54
Park, J. W., Kim, Y., Lee, S.-B., Oh, C. W., Lee, E. J., Ko, J. Y., & Park, J. H. (2021) · Molecular Oncology · doi:10.1002/1878-0261.13180 · Cited by 53
Wei, F., Rong, X., Xie, R., Jia, L.-T., Wang, H., Qin, Y., Chen, L., Shen, H.-F., Lin, X., Yang, J., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.5280 · Cited by 53
Hypoxia-Mediated Epigenetic Regulation of Stemness in Brain Tumor Cells
Prasad, P., Mittal, S. A., Chongtham, J., Mohanty, S., & Srivastava, T. (2017) · Stem Cells · doi:10.1002/stem.2621 · Cited by 54
Therapeutic potential of selective histone deacetylase 3 inhibition
Zhang, L., Chen, Y., Jiang, Q., Song, W., & Zhang, L. J. (2018) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2018.10.072 · Cited by 51
Notch Signaling in Hepatocellular Carcinoma: Guilty in Association!
Strazzabosco, M., & Fabris, L. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.10.025 · Cited by 52
Lemos, C., Hardt, M. S., Juneja, M., Voss, C., Förster, S., Jerchow, B., Haider, W., Bläker, H., & Stein, U. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-1425 · Cited by 54
3D chromatin architecture and epigenetic regulation in cancer stem cells
Feng, Y., Liu, X., & Pauklin, S. (2021) · Protein & Cell · doi:10.1007/s13238-020-00819-2 · Cited by 55
Oncofetal proteins and cancer stem cells
Yan, Q., Fang, X., Li, C., Lan, P., & Guan, X. (2022) · Essays in Biochemistry · doi:10.1042/ebc20220025 · Cited by 51
Lei, T., & Ling, X. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i35.10137 · Cited by 51
Huan, H.-B., Yang, D., Wen, X.-D., Chen, X., Zhang, L. N., Wu, L., Bie, P., & Xia, F. (2017) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-017-0559-4 · Cited by 51
Self-citation
Metadata
- Authors
- Shan, J., Shen, J., Liu, L., Xia, F., Xu, C., Duan, G., Xu, Y., Ma, Q., Yang, Z., Zhang, Q., Ma, L., Liu, J., Xu, S., Yan, X., Bie, P., Cui, Y., Bian, X.-W., & Qian, C.
- Affiliations
- Army Medical University (CN)
- Corresponding author
- Qian, Cheng
- ORCID
- Venue
- Hepatology
- Published
- 2012-09
- Volume
- 56
- Issue
- 3
- Pages
- 1004-1014
- ISSN
- 0270-9139 (ISSN-L)
- OpenAlex
- W1963590109
- Cited by
- 296
- References
- 37
- Citations by year
- 2026: 3 · 2025: 12 · 2024: 8 · 2023: 11 · 2022: 16 · 2021: 22 · 2020: 15 · 2019: 28 · 2018: 24 · 2017: 33 · 2016: 38 · 2015: 40 · 2014: 21 · 2013: 20 · 2012: 5
- FWCI
- 13.61
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Hepatology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Natural Science Foundation of China (973 Program, 81090423, 2010CB529406, 81101630)
- National Key Research and Development Program of China (2010CB529406)
- Topics
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
- Health Sciences › Medicine › Hepatology › Hepatocellular Carcinoma Treatment and Prognosis
- Keywords
- Nanog, hepatocellular carcinoma, cancer stem cells, self-renewal, insulin-like growth factor II, IGF1R signaling, pluripotency transcription factors, tumor initiation, drug resistance, sorafenib, cisplatin, tumor invasion and metastasis, stem cell markers
- MeSH terms
- Nanog Homeobox Protein, Carcinoma, Hepatocellular, Humans, Liver Neoplasms, Neoplastic Stem Cells, Signal Transduction, Receptor, IGF Type 1, Homeodomain Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
